World Health Organization site
Skip Navigation Links

Main
Note: This record shows only the 20 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 17 October 2012
Main ID:  NCT00989976
Date of registration: 01/10/2009
Primary sponsor: University of Chicago
Public title: Individual Differences in Diabetes Risk: Role of Sleep Disturbances
Scientific title: Individual Differences in Diabetes Risk: Role of Sleep Disturbances
Date of first enrolment: February 2009
Target sample size: 32
Recruitment status: Recruiting
URL:  http://clinicaltrials.gov/show/NCT00989976
Study type:  Interventional
Study design:  Allocation: Randomized, Intervention Model: Crossover Assignment, Masking: Open Label, Primary Purpose: Basic Science  
Countries of recruitment
United States
Contacts
Name:   Florian Chapotot, PhD
Address: 
Telephone: 773-834-3437
Email: fchapotot@uchicago.edu
Affiliation: 
Name:   Florian Chapotot, PhD
Address: 
Telephone:
Email: fchapotot@uchicago.edu
Affiliation: 
Name:   Eve Van Cauter, PhD
Address: 
Telephone:
Email:
Affiliation:  University of Chicago
Key inclusion & exclusion criteria

Inclusion Criteria:

- Healthy men and women with low Slow Wave Sleep Activity (SWA) or high SWA with the
gender distribution in each group matching the gender distribution of active duty
Army personnel (85% men; 15% women) based on the following inclusion criteria:

- age 18 to 29 years,

- normal weight or modestly overweight (BMI = 27 kg/m2 for women, BMI = 28 kg/m2
for men),

- normal findings on clinical examination, normal routine laboratory tests
results, normal EKG, no history of psychiatric, endocrine, cardiac or sleep
disorders.

- Only subjects who have regular life styles (no shift work, no travel across time zone
during the past 4 weeks), habitual bedtimes between 7.0-8.5 hours, and do not take
medications will be recruited.

- An overnight polysomnography will be performed to rule out sleep-disordered breathing
(apnea-hypopnea index > 5/hour) and periodic limb movement disorder (PLM arousal
index >1/hour).

- Women taking hormonal contraceptive therapy and pregnant women will be excluded. In
women, all studies will be initiated in the early follicular phase.

Exclusion Criteria:

- Tobacco use.

- Habitual alcohol use of more than 2 1 drink per day.

- Excessive caffeine intake of more than 300 mg per day and individuals with a metal
implant or another metal object in their body.

We estimate that we will need to recruit at least 60-70 individuals to obtain two
gender-matched groups of 16 individuals with either low or high SWA.



Age minimum: 18 Years
Age maximum: 29 Years
Gender: Both
Health Condition(s) or Problem(s) studied
Diabetes
Sleep
Intervention(s)
Behavioral: bedtime restriction
Behavioral: normal sleep times
Primary Outcome(s)
diabetes risk as assessed by disposition index [Time Frame: Dec. 2011]
Secondary Outcome(s)
Secondary ID(s)
#16028A
DOD PR064727
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.1 - Version history